Medicine
Retacrit 10000 IU/mL injection
Retacrit 10000 IU/mL injection is a prescription medicine containing Epoetin for intravenous, subcutaneous use, marketed by Pfizer Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. When exposed…
Key facts
- Active ingredient (INN)
- Epoetin
- Brand
- Retacrit
- Strength
- 10000 IU/mL
- Dosage form
- Injection
- Route
- Intravenous, subcutaneous
- Packs
- 10 vials and 1 more
- Marketing authorisation holder
- Pfizer Laboratories
- Manufacturers
- Pfizer LaboratoriesVifor (International)
- Origin register
- US FDA, United States
- Storage
- Store refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. When exposed to freezing temperatures, the green area of the freeze strip indicator in the carton of the multiple-dose vials will show signs of cloudy or white discoloration. Do not use RETACRIT that has been shaken or frozen or if the green area of the freeze strip indicator is cloudy or white. Do not shake.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B03XA02 Darbepoetin alfa
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 June 2018
- Identifiers
- RxCUI 2047591, 2047596, 2047600 +7DailyMed set ID 3af26b0d-8ad0-44e1-a538-8bdb5ab39374, e6e4dd0c-25ca-40b2-ba6b-6138a68621feNDC 0069-1318, 59353-220, 0069-1308 +1Application BLA125545
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 0069-1308-10 | Pfizer Laboratories | 18 June 2018 |
| 10 vial, multi-dose in 1 carton / 2 mL in 1 vial, multi-dose | 0069-1318-10 | Pfizer Laboratories | 9 November 2020 |
| 10 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 59353-010-10 | Vifor (International) | 18 June 2018 |
| 10 vial, multi-dose in 1 carton / 2 mL in 1 vial, multi-dose | 59353-220-10 | Vifor (International) | 9 November 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Epoetin 10000 IU/mL injection.
Other strengths and forms of Epoetin
Clinical summary
Epoetin is an erythropoiesis-stimulating agent indicated for treatment of anemia due to, among other approved uses. It is available as injection for intravenous and subcutaneous use. MedsAcross supplies Epoetin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EpoetinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- EPOGEN prescribing information (Amgen) · U.S. National Library of Medicine, DailyMed
Need Retacrit 10000 IU/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.